Skip to main content
. 2024 Apr 24;9(5):102924. doi: 10.1016/j.esmoop.2024.102924

Figure 1.

Figure 1

Kaplan–Meier curves of PFS in patients (A) with and (B) without BMs.

BMs, brain metastases; CI, confidence interval; HR, hazard ratio; mPFS, median progression-free survival; NE, not estimable; NR, not reached; PFS, progression-free survival; T-DM1, trastuzumab emtansine; T-DXd, trastuzumab deruxtecan.